|
Enter a Search String | | Special character and space not allowed in the query term.
Search string should be at least 2 characters long. |
Reaction List for pathway PLCbeta (Pathway Number 67) in Accession PLCbeta1 (Accession Number 13) | Entries are grouped according to Pathway Number and they are alternately color coded using  and  color.
Further ordering can be done to the table header.   indicates that ordering is done according to ascending or descending order.
Keq is calculated only for first order reactions.
Kd is calculated only for second order reactions. [nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules] |
| |
Reaction
Name | Pathway Name /
Pathway No. | Kf | Kb | Kd | tau | Reagents | | 1 | Gq-bind-Ca.PLCbe
ta | PLCbeta
Pathway No. 67 | 50
(uM^-1 s^-1) | 1
(s^-1) | Kd(bf) = 0.02(uM) | - | Substrate:
Gq
Ca.PLCbeta
Products:
Gq.Ca.PLCbeta
| | | 6 Nov 2001 The Kf and Kb values were fixed according to the response curves obtained from I. Litosch, Biochem., 2000, 39, 7736-7743. | | 2 | Ca_bind_PLCbeta | PLCbeta
Pathway No. 67 | 1
(uM^-1 s^-1) | 1
(s^-1) | Kd(bf) = 1(uM) | - | Substrate:
Ca
PLCbeta
Products:
Ca.PLCbeta
| | | 6 Nov 2001 The Kf and Kb values were fixed according to the dose response curves obtained from I.Litosch, Biochem., 2000, 39, 7736-7743. | | 3 | PA-bind-Ca.PLCbe
ta | PLCbeta
Pathway No. 67 | 1
(uM^-1 s^-1) | 8
(s^-1) | Kd(bf) = 8(uM) | - | Substrate:
PA
Ca.PLCbeta
Products:
PA.Ca.PLCbeta
| | | 6 Nov 2001 The Kf and Kb values were fixed according to the dose response curves obtained from I. Litosch, Biochem., 2000, 39, 7736-7743. | | 4 | Basal | PLCbeta
Pathway No. 67 | 0.009
(s^-1) | 0
(uM^-1 s^-1) | - | - | Substrate:
PIP2
Products:
DAG
IP3
| | | 6 Nov 2001 The basal reaction rates are fixed according to the respomse curves obtained from I. Litosch, Biochem.,2000, 39, 7736-7743. |
| Database compilation and code copyright (C) 2022, Upinder S. Bhalla and NCBS/TIFR
This Copyright is applied to ensure that the contents of this database remain freely available. Please see FAQ for details. |
|
